secwatch.observer — SEC 8-K summary
======================================

Issuer:     AdaptHealth Corp. (AHCO)
CIK:        0001725255
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0001628280-25-037598
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AdaptHealth Q2 2025 revenue $800.4M, net income $14.7M; lowers FY adjusted EBITDA guidance
--------------------------------------------------------------------------------

- Net revenue $800.4M, down 0.7% YoY; net income $14.7M vs $19.4M in prior year.
- Adjusted EBITDA $155.5M, down 5.9% YoY; year-to-date cash flow from ops $257.5M.
- FY 2025 revenue guidance narrowed to $3.18B-$3.26B; adjusted EBITDA lowered to $642M-$682M.
- Closed sales of certain incontinence and infusion assets in Wellness at Home segment.
- Announces new capitated partnership with a major national healthcare system (no details).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725255/000162828025037598/0001628280-25-037598-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725255/000162828025037598/ahco-20250805.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-037598

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer